Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Vrachimis

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
The Lancet. Oncology|April 2, 2026
[<sup>177</sup>Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 studyBastiaan M Privé, Walter Noordzij, Constantijn H J Muselaers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2023
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/mlNantia Solomonidou, Daphnie Germanou, Iosif Strouthos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 22, 2023
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomySonja Adebahr, Alexander Althaus, Sophia Scharl, et al.
JAMA Network Open|May 23, 2023
Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate CancerConstantinos Zamboglou, Jan C Peeken, Ali Janbain, et al.
JMIR Cancer|September 20, 2024
A Machine Learning Approach for Predicting Biochemical Outcome After PSMA-PET-Guided Salvage Radiotherapy in Recurrent Prostate Cancer After Radical Prostatectomy: Retrospective StudyAli Janbain, Andrea Farolfi, Armelle Guenegou-Arnoux, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After ProstatectomyConstantinos Zamboglou, Iosif Strouthos, Joerg Sahlmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global InitiativeAkram Al-Ibraheem, Andrew M Scott, Ahmed Saad Abdlkadir, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2023
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective studySophia Scharl, Constantinos Zamboglou, Iosif Strouthos, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The Lancet. Oncology|April 2, 2026
[<sup>177</sup>Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 studyBastiaan M Privé, Walter Noordzij, Constantijn H J Muselaers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2023
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/mlNantia Solomonidou, Daphnie Germanou, Iosif Strouthos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 22, 2023
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomySonja Adebahr, Alexander Althaus, Sophia Scharl, et al.
JAMA Network Open|May 23, 2023
Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate CancerConstantinos Zamboglou, Jan C Peeken, Ali Janbain, et al.
JMIR Cancer|September 20, 2024
A Machine Learning Approach for Predicting Biochemical Outcome After PSMA-PET-Guided Salvage Radiotherapy in Recurrent Prostate Cancer After Radical Prostatectomy: Retrospective StudyAli Janbain, Andrea Farolfi, Armelle Guenegou-Arnoux, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After ProstatectomyConstantinos Zamboglou, Iosif Strouthos, Joerg Sahlmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global InitiativeAkram Al-Ibraheem, Andrew M Scott, Ahmed Saad Abdlkadir, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2023
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective studySophia Scharl, Constantinos Zamboglou, Iosif Strouthos, et al.
Pageof 6